Regulus Therapeutics Inc.
RGLSDelisted Jun 25, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001505512
Regulus Therapeutics Inc. was delisted on Jun 25, 2025; its insiders filed their last Form 4 on Jun 27, 2025; 75 institutions reported holding it in 13F filings for Q1 2025, worth $107.0M in total; no superinvestor held it.
Q2 2024 vs. Q1 2024
How the institutions holding Regulus Therapeutics Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 45 | 63 | +18 |
| Shares | 52.1M | 61.3M | +9.24M (+17.7%) |
| Value | $147.3M | $109.5M | −$37.8M (−25.7%) |
New holders (28)
Institutions that held Regulus Therapeutics Inc. at the end of Q2 2024 but not at the end of Q1 2024.
Sold out (10)
Institutions that held Regulus Therapeutics Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Soleus Capital Management, L.P. | 1,562,500 | $4.50M |
| Polar Asset Management Partners Inc. | 536,400 | $1.54M |
| Exome Asset Management LLC | 402,504 | $1.16M |
| HRT Financial LP | 62,797 | $180.0K |
| Balyasny Asset Management LLC | 24,253 | $69.8K |
| Susquehanna International Group, LLP | 22,528 | $64.9K |
| CTC Alternative Strategies, Ltd. | 18,500 | $53.3K |
| Group One Trading, L.P. | 8,607 | $24.8K |
| Tower Research Capital LLC (TRC) | 3,212 | $9.25K |
| Macquarie Group Ltd | 865 | $2 |